Abstract

Abstract: Aortic endothelial cell cultures (PAE) from four lines of pigs transgenic for human decay‐accelerating factor (hDAF) have been used to study the response to the inflammatory stimuli bacterial lipopolysaccharide (LPS) and recombinant human TNF‐α. Human umbilical vein endothelial cells (HUVEC) and PAE from normal, non‐transgenic pigs were used as controls. The expression of hDAF and E‐selectin on the cell surface was determined by flow cytometry. After overnight incubation, HUVEC, normal and transgenic PAE increased the relative expression of E‐selectin 2–5‐fold in response to LPS (25 μg/ml), and 5–40‐fold in response to TNF‐α(10 ng/ml). In both normal and transgenic PAE the increase in expression of E‐selectin in response to TNF‐α was maximal at 4 hr and significantly decreased after 20 hr. There was no significant increase in DAF expression by HUVECs in response to LPS or TNF‐α, and three of the four lines of transgenic pigs studied did not increase expression of hDAF in response to either stimulus. However, endothelial cells from the transgenic line A74 exhibited a dose‐dependent increase in expression of hDAF in response to LPS and TNF‐α. A study of the time course of up‐regulation triggered by incubation with TNF‐α showed that, in contrast to the up‐regulation of E‐selectin, hDAF expression continued to increase for at least 3 days. This response may afford additional protection to organs from this line of transgenic pigs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.